CTRI/2019/05/019453
Not Yet Recruiting
Phase 2
Evaluation of haemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in participants undergoing laproscopic appendicectomy:A prospective randomized parallel group double blind clinical trial.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Government medical college Bhavnagar
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Informed written consent
- •2\)18 to 50 years of age
- •3\)Patient is of either gender
- •4\)ASA physical status I and II
- •5\)Undergoing elective laproscopic appendicectomy
- •6\)Requiring endotracheal intubation
Exclusion Criteria
- •1\)Refusing to give consent
- •2\)Anticipated difficult airway
- •3\)Pre existing liver or renal failure
- •4\)Therapy with drug known to interfere with neuromuscular transmission
- •5\)Antenatal and lactating females
- •6\)Prolonged preoperative bed rest
- •7\)Patient having neuromuscular disorders
- •8\)ASA physical status III and IV
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 3
Effect of Cold local Anaesthesia on high blood pressure patients during root canal treatmentCTRI/2022/09/045941SRM Dental College
Completed
N/A
Clinical investigation into efficacy, haemodynamics and tolerability of simvastatin versus placebo in patients with pulmonary arterial hypertensioPulmonary hypertensionCirculatory SystemOther pulmonary heart diseasesISRCTN27178415niversity Hospital Giessen (Germany)40
Active, Not Recruiting
N/A
Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHTModified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9MedDRA version: 8.1Level: LLTClassification code 10020787Term: Hypertension pulmonaryEUCTR2005-004863-41-DEDept. of Internal Medicine II, University Hospital Giessen40
Completed
Phase 2
Assessment Of Hemodinamic Effect Of PropofolPropofol adverse events.Other and unspecified general anaestheticsY 48.2IRCT2013093014831N1Ahvaz Jundishapour University Of Medical Sciences58
Not Yet Recruiting
Phase 1
Pain relief from epidural in laparoscopic surgeryHealth Condition 1: K928- Other specified diseases of the digestive systemHealth Condition 2: K928- Other specified diseases of the digestive systemCTRI/2018/12/016559Amrita Institute of Medical Sciences